ArticleShock (Augusta, Ga.)2026
Identifying a Refractory Shock Phenotype in Pediatric Sepsis Using a Vasoactive-Adjusted Shock Index.
Article in Shock (Augusta, Ga.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesThis study aimed to: 1) develop a cardiovascular index that includes hemodynamic status and adjusts for vasoactive medication use; 2) identify pediatric patients with refractory septic shock (RSS) using early trends of the adjusted index, and 3) assess the heterogeneity of treatment effect (HTE) to common adjuvant therapies in RSS versus non-RSS patients.
methodsChildren with sepsis across 13 US pediatric intensive care units between 2012 and 2018 were included. The vasoactive-adjusted shock index (VASI) was derived using the shock index (heart rate/systolic pressure) and adjusted for vasoactive use. Group-based trajectory modeling was applied to 8-hour VASI trends following pediatric intensive care unit admission to stratify patients and replicated using K-means with dynamic time warping. HTE between RSS and non-RSS patients was analyzed using inverse-probability weighted logistic regression.
results17,216 patients were included (8.6% mortality). VASI demonstrated a robust progressive increase in clinical risk, outperforming other hemodynamic metrics at discriminating poor outcomes. Trajectory analysis identified four clusters, including a trajectory with persistently high VASI consistent with an RSS clinical phenotype. Unlike fluid balance and albumin use, hydrocortisone use on the first day was associated with lower mortality among RSS patients than among non-RSS patients (interaction, P = 0.002).
conclusionThe early trajectory of VASI identifies an RSS clinical phenotype associated with poor outcomes and HTE to adjuvant therapies. Integrating hemodynamic status and vasoactive use into early risk assessment in pediatric sepsis can help identify a high-risk RSS group, with both prognostic and therapeutic relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.